Skip to main content

Advertisement

Table 3 Clinical and pathological features of the 120 RCT patients included in the study

From: Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel

  Tumour
Number of patients, n 120
Age, median (range) 60 (29–83)
Gender, n (%)
 Male 73 (61)
 Female 47 (39)
Histological subtype, n (%)
 Clear cell RCC 30 (25)
 Papillary RCC 30 (25)
 Chromophobe RCC 30 (25)
 Oncocytoma 30 (25)
Pathological stage, n (%)
 Stage I 47 (39)
 Stage II 19 (16)
 Stage III 21 (17.5)
 Stage IV 3 (2.5)
 n.a. (oncocytoma) 30 (25)
Nuclear grade, n (%)
 Grade 1 3 (2.5)
 Grade 2 23 (19)
 Grade 3 29 (24.5)
 Grade 4 5 (4)
 n.a. (chRCC and oncocytoma) 60 (50)
Metastasis during follow-up
 Clear cell RCC 9 (7.5)
 Papillary RCC 7 (5.8)
 Chromophobe RCC 1 (0.8)
  1. RCC renal cell carcinoma, chRCC chromophobe renal cell carcinoma, n.a. not applicable